194 related articles for article (PubMed ID: 37333805)
1. The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends.
Chu Y; Liu Y; Fang X; Jiang Y; Ding M; Ge X; Yuan D; Lu K; Li P; Li Y; Xu H; Fan J; Zhou X; Wang X
Front Oncol; 2023; 13():1059914. PubMed ID: 37333805
[TBL] [Abstract][Full Text] [Related]
2. Global burden, risk factors, and trends of non-Hodgkin lymphoma: A worldwide analysis of cancer registries.
Huang J; Chan SC; Lok V; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS
Cancer Med; 2024 Mar; 13(5):e7056. PubMed ID: 38477498
[TBL] [Abstract][Full Text] [Related]
3. Trends Analysis of Non-Hodgkin Lymphoma at the National, Regional, and Global Level, 1990-2019: Results From the Global Burden of Disease Study 2019.
Cai W; Zeng Q; Zhang X; Ruan W
Front Med (Lausanne); 2021; 8():738693. PubMed ID: 34631756
[No Abstract] [Full Text] [Related]
4. Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017.
Sun H; Xue L; Guo Y; Du J; Nan K; Li M
Ann Med; 2022 Dec; 54(1):633-645. PubMed ID: 35196922
[TBL] [Abstract][Full Text] [Related]
5. Burden of lymphoma in China, 2006-2016: an analysis of the Global Burden of Disease Study 2016.
Liu W; Liu J; Song Y; Zeng X; Wang X; Mi L; Cai C; Wang L; Ma J; Zhu J; ;
J Hematol Oncol; 2019 Nov; 12(1):115. PubMed ID: 31744509
[TBL] [Abstract][Full Text] [Related]
6. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends.
Huang J; Chan SC; Lok V; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS;
Lancet Haematol; 2022 Sep; 9(9):e670-e677. PubMed ID: 35843248
[TBL] [Abstract][Full Text] [Related]
7. Global patterns of non-Hodgkin lymphoma in 2020.
Mafra A; Laversanne M; Gospodarowicz M; Klinger P; De Paula Silva N; Piñeros M; Steliarova-Foucher E; Bray F; Znaor A
Int J Cancer; 2022 Nov; 151(9):1474-1481. PubMed ID: 35695282
[TBL] [Abstract][Full Text] [Related]
8. Global burden and temporal trends in incidence and mortality of oesophageal cancer.
Zhou B; Bie F; Zang R; Zhang M; Song P; Liu L; Peng Y; Bai G; Huai Q; Li Y; Zhao L; Gao S
J Adv Res; 2023 Aug; 50():135-144. PubMed ID: 36272715
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Global, Regional, and National Burden and Trends of Down Syndrome From 1990 to 2019.
Chen L; Wang L; Wang Y; Hu H; Zhan Y; Zeng Z; Liu L
Front Genet; 2022; 13():908482. PubMed ID: 35910218
[No Abstract] [Full Text] [Related]
11. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.
Deng Y; Zhao P; Zhou L; Xiang D; Hu J; Liu Y; Ruan J; Ye X; Zheng Y; Yao J; Zhai Z; Wang S; Yang S; Wu Y; Li N; Xu P; Zhang D; Kang H; Lyu J; Dai Z
J Hematol Oncol; 2020 Jul; 13(1):98. PubMed ID: 32690044
[TBL] [Abstract][Full Text] [Related]
12. Global Trends in Incidence and Burden of Urolithiasis from 1990 to 2019: An Analysis of Global Burden of Disease Study Data.
Lang J; Narendrula A; El-Zawahry A; Sindhwani P; Ekwenna O
Eur Urol Open Sci; 2022 Jan; 35():37-46. PubMed ID: 35024630
[TBL] [Abstract][Full Text] [Related]
13. Global patterns and trends in the incidence of non-Hodgkin lymphoma.
Miranda-Filho A; Piñeros M; Znaor A; Marcos-Gragera R; Steliarova-Foucher E; Bray F
Cancer Causes Control; 2019 May; 30(5):489-499. PubMed ID: 30895415
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
15. Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling study.
Chen Y; Zhao J; Sun P; Cheng M; Xiong Y; Sun Z; Zhang Y; Li K; Ye Y; Shuai P; Huang H; Li X; Liu Y; Wan Z
EClinicalMedicine; 2024 Jan; 67():102370. PubMed ID: 38130708
[TBL] [Abstract][Full Text] [Related]
16. The burden of non-Hodgkin lymphoma in Central and South America.
Diumenjo MC; Abriata G; Forman D; Sierra MS
Cancer Epidemiol; 2016 Sep; 44 Suppl 1():S168-S177. PubMed ID: 27678319
[TBL] [Abstract][Full Text] [Related]
17. The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019.
Chen H; Zhan Y; Zhang J; Cheng S; Zhou Y; Chen L; Zeng Z
JMIR Public Health Surveill; 2022 Dec; 8(12):e34809. PubMed ID: 36508249
[TBL] [Abstract][Full Text] [Related]
18. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
GBD 2017 Stomach Cancer Collaborators
Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):42-54. PubMed ID: 31648970
[TBL] [Abstract][Full Text] [Related]
19. Worldwide suicide mortality trends (2000-2019): A joinpoint regression analysis.
Ilic M; Ilic I
World J Psychiatry; 2022 Aug; 12(8):1044-1060. PubMed ID: 36158305
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
